News

The BSMA Europe annual event taking place in Brussels on May 19^th 2016 will be the launch event of the BSMA Europe Community.

Biolog Europe and BSMA USA join forces to launch BSMA Europe, the first european association in life sciences supply chain !

Franck Toussaint, Managing Director of Biolog Europe and expert in the global "life science" supply chain as been invited at the upcoming "Bio Supply Management Alliance" happening in San Francisco on October 15th & 16th (Crowne Plaza, 1221 Chess Drive Foster City, CA 94404) 

He will be presenting the following topic : “ID for Medicinal Products: Preparing for the EMA Regulation” 

Celyad SA (formerly known as Cardio3 BioSciences) (Euronext Brussel:CYAD) (Paris:CYAD), announced the pricing of its global offering totaling $100.1 million gross proceeds of 1,460,000 new ordinary shares, consisting of 1,168,000 American Depositary Shares ("ADSs") at $68.56 per ADS, and 292,000 ordinary shares at a price of EUR 60.25 per share, both before underwriting discounts. 

Biolog Europe Expert's team will be present at the upcoming BIO in Philadelphia. Come and visit us at the Belgian Pavillon to discuss about your European challenges & vision!

It is in the dedicated pharma workshop that Franck Toussaint, managing director of Biolog Europe, will approach the key regulatory aspects in comparing the GDP (Good Distribution Practice) regulation and its EU’s involvement vs the new IATA CEIV regulation (Center of Excellence for Independent Validators) also dedicated for the life science industry.

 

 

Wishing you every happiness 
this holiday season and throughout the coming year. 

The BioLog Europe's team.

• Cardio3 BioSciences acquires CorQuest Medical Inc. and its unique heart access platform that could receive CE marking by end 2016.

• Acquisition includes medical devices and implants expanding Cardio3 BioSciences’ cardiovascular therapeutic applications’ portfolio.

SENEFFE, Belgium—Dow Corning Corp. opened an expanded health care application center at its European headquarters.
 

The firm said the facility combines its expertise in silicone materials with leading-edge application development equipment to support advances in medical, pharmaceutical and health care technologies.

According to the World Health Organization, five out of 100 essential drugs were invented in Belgium, while Nature Review listed Belgium in its top 10 innovative ‘pharma valleys’ in the world.

In clinical trials, Belgium has the second highest number of protocols in Europe and among the highest number of patients per capita in studies.

And in manufacturing and distribution, Belgium holds the second position in the export of pharmaceuticals worldwide – in absolute volume! Out of every eight products that leave this country, one is a pharmaceutical.

With a thorough understanding of the intricacy of pharma products transportation, Qatar Airways Cargo offers well-designed service that provides optimal conditions for Life Science shipments across the world.

C.A.L. Cargo Air Lines, announced today the first flight from Greater Moncton International Airport (YQM), Canada to Liege, Belgium. Originating at JFK, this is the first 747 aircraft to land on Greater Moncton International Airport’s newly expanded runway. The flight, containing a full payload then flew to Liege Airport, Belgium, where it was handled by CAL’s wholly owned ground handling agent, LACHS.